NEU has a good licensing agreement with a US company, and indicated they had interest from others. I don’t really doubt that for the right AUS company, such as RAC which has a unique proposition, there will be interest from international pharma (not necessarily US)
CU6 - Media and Industry News, page-57
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.27 |
Change
0.230(3.81%) |
Mkt cap ! $2.010B | |||
| Open | High | Low | Value | Volume |
| $6.14 | $6.40 | $6.07 | $5.460M | 875.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 1764 | $6.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.28 | 3831 | 14 |
View Market Depth
| Last trade - 12.27pm 19/11/2024 (20 minute delay) ? |
| CU6 (ASX) Chart |